BRAF and colorectal carcinoma: We found that CRC patients with the BRAFV600E mutation exhibited significantly higher transcript levels of OPNa, OPNb, and OPNc compared to those with wild-type patients presenting BRAF (p = 0.007, p = 0.03 and p = 0.04, respectively) (Table 2).